Latest Breaking News On - Innovation authority magneton program - Page 1 : vimarsana.com

Hypoxia radioactive marker will detect aggressiveness of tumors, eliminating the need for biopsy Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients. The probability of cure depends largely on the type of cancer tumor and the stage at which the disease is discovered. Accurate means of diagnosis in the early stages is key to saving lives. New Israeli research is being conducted to develop a hypoxia radioactive marker (a phenomenon of lack of oxygen in cells) based on the Copper 64 isotope to identify oxygen-deficient cells. Studies have shown that oxygen concentration in the cell is directly related to the aggressiveness of cancerous tumors. The hypoxia radioactive marker will not only determine if the tumor is malignant or benign, but also how aggressive it is through a single image, eliminating the need for a biopsy.

Sharon ruthsteinKeren moshkovizEmily hendersonInnovation authority magneton programIsotopia molecular imaging ltdIlan universityDevelopment company ltdDepartment of chemistry at barBusiness development at isotopiaBar ilan universityBusiness developmentInnovation authorityஎமிலி ஹென்டர்சன்இலன் பல்கலைக்கழகம்வளர்ச்சி நிறுவனம் லிமிடெட்துறை ஆஃப் வேதியியல் இல் மதுக்கூடம்